The guideline of prevention and treatment for chronic hepatitis B (2010 version)
Jia, J-Dong.; Li, L-Juan.
Zhonghua Liu Xing Bing Xue Za Zhi 32(4): 405-415
2011
ISSN/ISBN: 0254-6450 PMID: 21569677 Document Number: 651252
Document emailed within 1 workday
Related Documents
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76Gadano, Aán.; Daruich, J.; Cheinquer, H.; Faimboin, H.; Pessoa, M.; Tanno, H.; Mattos, A.; Silva, M.; Paraná, R.; Galoppo, C.; Porta, G.; Garassini, M.; Ferrandiz, J.; Dávalos, M.; Galdame, O.; Marciano, Sán.; Ballerga, E.González.; Bessone, F.; Hernández, N.; Fassio, E.; Poniachik, J.; Strauss, E. 2011: Latin American guideline for the management of chronic hepatitis B Acta gastroenterologica Latinoamericana 41(4): 340-350
Lumio, J.; Vuoristo, M. 1994: Treatment and prevention of chronic viral hepatitis Duodecim; Laaketieteellinen Aikakauskirja 110(20): 1883-1892
Shi, Y. 2015: The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version) Zhonghua Zhong Liu Za Zhi 37(10): 796-799
Majstorović, B.; Janković, S.; Dimoski, Z.; Kekuš, D.; Kocić, S.; Mijailović, Željko. 2015: Assessment of the Reliability of the Serbian Version of the Sickness Impact Profile Questionnaire in Patients with Chronic Viral Hepatitis Srpski Arhiv Za Celokupno Lekarstvo 143(11-12): 688-694
Koriyama, K. 2003: A proposal guideline for Japanese version of AHLS Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 16(4): 427-431
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Dietlein, M.; Dressler, J.; Grünwald, F.; Joseph, K.; Leisner, B.; Moser, E.; Reiners, C.; Rendl, J.; Schicha, H.; Schneider, P.; Schober, O. 2003: Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2) Nuklearmedizin. Nuclear Medicine 42(3): 109-115
Liu, X. 2014: Guideline of prevention and treatment about postpartum hemorrhage (2014) Zhonghua Fu Chan Ke Za Zhi 49(9): 641-646
Dietlein, M.; Dressler, J.; Eschner, W.; Leisner, B.; Reiners, C.; Schicha, H. 2003: Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2) Nuklearmedizin. Nuclear Medicine 42(3): 123-125
Arauz, A.; Murillo-Bonilla, L.; Leyva, A.; Barinagarrementeria, F.; Alegria, M.Antonio.; Villarreal-Careaga, J.; León, C.; Cantú, C.; Ruíz-Sandoval, Jé.Luis. 2010: Guideline for secondary prevention treatment in cerebrovascular diseases after acute phase Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(2): 130-134
Randel, A. 2016: ACCP Releases Guideline for the Treatment of Unexplained Chronic Cough American Family Physician 93(11): 950
Ter Wee, P.M.; Jorna, A.T. 2004: Treatment of patients with chronic renal insufficiency; a guideline for internists Nederlands Tijdschrift Voor Geneeskunde 148(15): 719-724
Pongpipat, D.; Suvatte, V.; Assateerawatts, A. 1986: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg Asian Pacific Journal of Allergy and Immunology 4(1): 33-36
Shen, K-Ling.; Yang, Y-Hong.; Jiang, R-Meng.; Wang, T-You.; Zhao, D-Chi.; Jiang, Y.; Lu, X-Xia.; Jin, R-Ming.; Zheng, Y-Jie.; Xu, B-Ping.; Xie, Z-De.; Liu, Z-Sheng.; Li, X-Wang.; Lin, L-Kai.; Shang, Y-Xiao.; Shu, S-Nan.; Bai, Y.; Lu, M.; Lu, G.; Deng, J-Kui.; Luo, W-Jun.; Xiong, L-Juan.; Liu, M.; Cui, Y-Xia.; Ye, L-Ping.; Li, J-Fu.; Shao, J-Bo.; Gao, L-Wei.; Wang, Y-Yan.; Wang, X-Feng. 2020: Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition) World Journal of Pediatrics: Wjp 16(3): 232-239
Achterberg, W.P.; de Ruiter, C.M.; de Weerd-Spaetgens, C.M.E.E.; Geels, P.; Horikx, A.; Verduijn, M.M. 2012: Multidisciplinary guideline 'Recognition and treatment of chronic pain in vulnerable elderly people' Nederlands Tijdschrift Voor Geneeskunde 155(35): A4606
McCreaddie, M. 2001: The hepatitis viruses. 2. Testing for hepatitis, treatment and prevention Nursing Times 97(48): 41-44
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905